ArticleBMC cancer2021

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment.

Liting Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.